Biotech Growth: Navigating Expansion and Ethical Challenges
The biotechnology sector continues to attract strong investor interest as late-stage firms advance toward commercialisation. September 2025 has seen a surge in capital directed at companies delivering clinical breakthroughs, scalable manufacturing and rapid expansion into global markets. Unlike earlier-stage ventures, today’s biotech investments increasingly favour businesses with proven trial results, experienced leadership and robust paths […]
